Tag: percutaneous coronary intervention

WOEST Trial Summary: Clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing PCI

Post author By admin
Post date May 17, 2023
Categories In Cardiovascular Disease

WOEST Trial Summary The WOEST trial, a groundbreaking study published in The Lancet, has shed light on a significant issue faced by patients undergoing percutaneous coronary intervention (PCI) while taking oral anticoagulants. Traditionally, triple therapy involving aspirin and clopidogrel has been recommended, but it comes with an increased risk of severe bleeding. The trial aimed […]